APAC Life Sciences Valuation Trends: Chinese Firms Eclipse Japan, India Peers
Emerging Innovation Driving Values?
Chinese healthcare and life sciences firms now overshadow their peers in Japan and India in terms of key valuation metrics amid COVID-19 and China has also witnessed significant M&A activity at high revenue multiples.
